503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.78%
Revenue growth below 50% of ORCL's 40.81%. Michael Burry would check for competitive disadvantage risks.
No Data
No Data available this quarter, please select a different quarter.
11.78%
Gross profit growth below 50% of ORCL's 40.81%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-273.15%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-254.90%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-273.15%
Both companies show declining income. Martin Whitman would check industry conditions.
-254.90%
Both companies show margin pressure. Martin Whitman would check industry conditions.
273.15%
Similar other expenses growth to ORCL's 259.52%. Walter Schloss would investigate industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
EPS decline while ORCL shows 0.00% growth. Joel Greenblatt would examine position.
-50.00%
Diluted EPS decline while ORCL shows 0.00% growth. Joel Greenblatt would examine position.
0.68%
Share count change of 0.68% while ORCL is stable. Bruce Berkowitz would verify approach.
0.68%
Diluted share change of 0.68% while ORCL is stable. Bruce Berkowitz would verify approach.